Learn more about the OX40-OX40L pathway and 2 drugs heading toward phase 3 trials.
Aderonke Adeboye, PharmD, BCPS
Advertisement
Articles by Aderonke Adeboye, PharmD, BCPS
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Dermatology Times
1
Transformative Advances This Year and Beyond
2
FDA Proposes Expansion of US Sunscreen Ingredient Standards with Bemotrizinol
3
Phase 3b Study Confirms Ligelizumab’s Consistent CSU Control
4
"PDE4 Inhibitor-Responsive Dermatoses": A Modern Framework for Managing Inflammatory Skin Conditions
5
